These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 12926202)
21. [Adherence to treatment by patients with depression and bipolar affective disorder]. Hansen HV; Kessing LV Ugeskr Laeger; 2005 Apr; 167(17):1837-41. PubMed ID: 15929328 [No Abstract] [Full Text] [Related]
22. Financial ties to industry cloud major depression study; at issue: whether it's safe for pregnant women to stay on medication; JAMA asks author to explain. Armstrong D Wall St J (East Ed); 2006 Jul; ():A1, A9. PubMed ID: 16909497 [No Abstract] [Full Text] [Related]
23. Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy. Nierenberg AA; Petersen TJ; Alpert JE J Clin Psychiatry; 2003; 64 Suppl 15():13-7. PubMed ID: 14658986 [TBL] [Abstract][Full Text] [Related]
24. Depression: benefiting from treatment advances. Johns Hopkins Med Lett Health After 50; 1998 Nov; 10(9):4-5. PubMed ID: 9803181 [No Abstract] [Full Text] [Related]
25. [Recurrence of depression caused by pharmacies]. Brødsgaard M Ugeskr Laeger; 2001 Aug; 163(34):4602-4. PubMed ID: 11530576 [No Abstract] [Full Text] [Related]
29. Antidepressants in pediatric oncology. Clerici CA; Simonetti F; Massimino M; Fossati-Bellani F Pediatr Blood Cancer; 2008 Jun; 50(6):1290-1; author reply 1291-2. PubMed ID: 18300315 [No Abstract] [Full Text] [Related]
30. Generalizability of antidepressant efficacy trials. Zimmerman M; Posternak MA; Chelminski I Essent Psychopharmacol; 2004; 6(1):45-58. PubMed ID: 15612653 [No Abstract] [Full Text] [Related]
31. Brightening depression. Wirz-Justice A; Terman M; Oren DA; Goodwin FK; Kripke DF; Whybrow PC; Wisner KL; Wu JC; Lam RW; Berger M; Danilenko KV; Kasper S; Smeraldi E; Takahashi K; Thompson C; van den Hoofdakker RH Science; 2004 Jan; 303(5657):467-9. PubMed ID: 14739440 [No Abstract] [Full Text] [Related]
32. Establishing the real cost of depression. Sheehan DV Manag Care; 2002 Aug; 11(8 Suppl):7-10; discussion 21-5. PubMed ID: 12233202 [No Abstract] [Full Text] [Related]
33. Long term pharmacotherapy of depression. Can reduce relapses and recurrences in major depression. Edwards JG BMJ; 1998 Apr; 316(7139):1180-1. PubMed ID: 9552990 [No Abstract] [Full Text] [Related]
34. [Various forms of risk factors of antidepressive agents for influencing sexual functions. Moclobemid is first choice for the therapy of sexually active patients with depression]. Fortschr Neurol Psychiatr; 1999 May; 67(5 Suppl Unterschie):1-4. PubMed ID: 10368779 [No Abstract] [Full Text] [Related]
35. Combination pharmacotherapy in unipolar depression. Ng F; Dodd S; Berk M Expert Rev Neurother; 2006 Jul; 6(7):1049-60. PubMed ID: 16831118 [TBL] [Abstract][Full Text] [Related]
36. Antidepressant choices in primary care: which to use first? Hansen S WMJ; 2004; 103(6):93-8. PubMed ID: 15622828 [No Abstract] [Full Text] [Related]
37. [Antidepressive treatment in general practice]. Mabeck CE; Rosenberg R Ugeskr Laeger; 1997 Jan; 159(3):264. PubMed ID: 9054065 [No Abstract] [Full Text] [Related]
38. Eighteen months of drug treatment for depression: predicting relapse and recovery. Mulder RT; Frampton CM; Luty SE; Joyce PR J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590 [TBL] [Abstract][Full Text] [Related]
39. Can the findings of antidepressant efficacy trials be extrapolated to the general population of depressed patients? Interview by Dr. Frederic Flach. Zimmerman M Essent Psychopharmacol; 2005; 6(2):118-25. PubMed ID: 15765796 [No Abstract] [Full Text] [Related]